Altanserin hydrochloride hydrate
SIGMA/A8106 - ≥98% (HPLC), solid
Synonym: 3-
CAS Number: 76330-71-7 (free base)
Empirical Formula (Hill Notation): C22H22FN3O2S · HCl · xH2O
Molecular Weight: 447.95 (anhydrous basis)
MDL Number: MFCD11045280
Linear Formula: C22H22FN3O2S · HCl · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | solid |
| InChI | 1S/C22H22FN3O2S.ClH.H2O/c |
| InChI key | MFGBKMPKRJCLPK-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O.Cl.Fc1ccc(cc1)C(=O)C2CC |
| solubility | DMSO: >5 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Application: | Altanserin hydrochloride hydrate has been used in the pretreatment of rat brain samples and as a non-radioactive control in the calibration curve preparation for quantifying [18F]altanserin in high-performance liquid chromatography. |
| Application: | Altanserin hydrochloride hydrate is a specific 5-HT2/serotonergic antagonist and has been used in a study to assess serotonin release capacity in the human brain. |
| Biochem/physiol Actions: | Altanserin hydrochloride hydrate is a specific 5-HT2/serotonergic antagonist. |
| Biochem/physiol Actions: | The radioligand of altanserin, [18F]altanserin is useful as a positron emission tomography (PET)-radioligand for the visualization and quantification of serotonin2A (5-HT2A) receptors. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H319 |
| Precautionary statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


